Lv1
40 积分 2022-05-16 加入
OK
Reprogramming of T Cells to Natural Killer–Like Cells uponBcl11bDeletion
3天前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
3天前
已完结
The development of academic CAR T cells
4天前
已完结
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
10天前
已完结
Cell therapy products are revolutionizing multiple therapeutic areas; to maintain this pace of innovation, manufacturing solutions must adapt
11天前
已完结
Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing – Towards the Development of a Platform Approach
12天前
已完结
END-TO-END AUTOMATED MANUFACTURING OF AUTOLOGOUS CAR T CELL THERAPIES WITH THE NEW SEFIA™ CELL THERAPY MANUFACTURING PLATFORM
1个月前
已完结
Natural killer cell therapies
1个月前
已完结
T cell receptor-engaging monoclonal antibodies mobilize the anti-tumor functions of invariant natural killer T cells
1个月前
已关闭
CAR Assembly Line: Taking CAR T-Cell Manufacturing to the Next Level
1个月前
已完结
皖公网安备34019202002308
